Seth Klarman Cullinan Oncology, Inc. Transaction History

Baupost Group LLC

  • $3.52 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$11.82 - $15.42 $13.1 Million - $17.1 Million
-1,105,914 Reduced 72.02%
429,646 $5.51 Million
Q4 2021

Feb 11, 2022
SELL
$15.36 - $25.0 $4.61 Million - $7.5 Million
-300,000 Reduced 16.34%
1,535,560 $22.5 Million
Q1 2021

May 14, 2021
BUY
$28.0 - $53.42 $51.4 Million - $98.1 Million
1,835,560 New
1,835,560 $71.7 Million

Others Institutions Holding CGEM

# of Institutions
146
Shares Held
67.6M
Call Options Held
612K
Put Options Held
118K
View Full List

About Cullinan Oncology, Inc.

CGEM Quotes by TradingView
  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $613M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track Seth Klarman's Portfolio

Track Seth Klarman Portfolio

Follow Seth Klarman (Baupost Group LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baupost Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baupost Group LLC and Seth Klarman with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email